The Enterprise Value as of September 2024 (TTM) for Axsome Therapeutics, Inc. (AXSM) is 4.35B

According to Axsome Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.35B. This represents a change of 25.45% compared to the average of 3.47B of the last 4 quarters.

Axsome Therapeutics, Inc. (AXSM) Historical Enterprise Value (quarterly & annually)

How has AXSM Enterprise Value performed in the past?

The mean historical Enterprise Value of Axsome Therapeutics, Inc. over the last ten years is 1.45B. The current 4.35B Enterprise Value has changed 29.91% with respect to the historical average. Over the past ten years (40 quarters), AXSM's Enterprise Value was at its highest in in the June 2024 quarter at 3.73B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.

Axsome Therapeutics, Inc. (AXSM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Axsome Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axsome Therapeutics, Inc. (AXSM) Average Enterprise Value

How has AXSM Enterprise Value performed in the past?

The current Enterprise Value of Axsome Therapeutics, Inc. (AXSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Axsome Therapeutics, Inc. (AXSM) Enterprise Value vs. Peers

How is AXSM’s Enterprise Value compared to its peers?

Axsome Therapeutics, Inc.’s Enterprise Value is less than Incyte Corporation (10.85B), less than ImmunoGen, Inc. (8.19B), less than Sarepta Therapeutics, Inc. (13.28B), greater than ACADIA Pharmaceuticals Inc. (2.55B), less than Viking Therapeutics, Inc. (5.95B), less than Madrigal Pharmaceuticals, Inc. (4.91B), greater than Seres Therapeutics, Inc. (286.75M), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than TG Therapeutics, Inc. (3.44B), greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Hepion Pharmaceuticals, Inc. (2.24M), greater than Akero Therapeutics, Inc. (1.56B), less than Reata Pharmaceuticals, Inc. (6.68B), greater than Day One Biopharmaceuticals, Inc. (1.01B), less than Blueprint Medicines Corporation (6.16B), greater than PDS Biotechnology Corporation (74.53M), greater than Amylyx Pharmaceuticals, Inc. (89.50M),

Build a custom stock screener for Axsome Therapeutics, Inc. (AXSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axsome Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axsome Therapeutics, Inc. (AXSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axsome Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.